About
Catalya develops synthetic polymer technologies to enhance drug delivery absorption for small molecules and biopharmaceuticals and to improve scalability and efficiency of adherent cell culture in pharmaceutical applications.
Explore CATALYA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.